| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers P > Headlines for Pfizer Inc. > News item |
Pfizer to price 30-year Taipei Exchange-listed notes via bookrunners BNP and Deutsche Bank
By Cristal Cody
Tupelo, Miss., Feb. 24 – Pfizer Inc. plans to price an offering of 30-year dollar-denominated notes, according to a 424B3 filing with the Securities and Exchange Commission on Friday.
BNP Paribas, Taipei Branch, and Deutsche Bank AG, Taipei Branch, are the bookrunners.
The notes are redeemable on or after 2020 at par.
The company will apply to list the notes on the Taipei Exchange.
Proceeds will be used for general corporate purposes, including to repay a portion of outstanding commercial paper. As of Feb. 22, Pfizer had about $6.6 billion of outstanding commercial paper.
The biopharmaceutical company is based in New York.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.